Doctor of Optometry Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Chandra Mickles

Optometrist Davie, FL Doctor of Optometry

NPI 1831326321 CMS profile 264402

3200 S University Dr, Davie, FL 33328

Open in the dashboard

General payments

$68,002

130 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Chandra Mickles of Davie, FL is reported in the CMS Open Payments database as having received $68,002 across 130 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $28 1
2021 General $13,757 28
2020 General $19,911 35
2019 General $34,306 66

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chandra Mickles
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Chandra Mickles were reported at $0. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Chandra Mickles Optometrist median Middle half National median
2019 $34,306 $159 $67–$371 $163
2020 $19,911 $72 $29–$165 $114
2021 $13,757 $125 $46–$292 $132
2022 $28 $162 $66–$374 $149
2023 $0 $177 $72–$406 $160
2024 $0 $188 $77–$427 $164
2025 $0 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Johnson & Johnson Vision Care, Inc. $36,500 70 payments
  2. Alcon Vision LLC $25,042 37 payments
  3. Sun Pharmaceutical Industries Inc. $4,177 10 payments
  4. Novartis Pharmaceuticals Corporation $1,454 5 payments
  5. Alcon Research LLC $398 1 payment
  6. Shire North American Group Inc $229 2 payments
  7. MacuLogix, Inc. $113 1 payment
  8. Allergan Inc. $32 2 payments
  9. CooperVision Inc. $30 1 payment
  10. Baxter Healthcare $28 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,414 37 payments
  2. Consulting Fee $20,423 12 payments
  3. Travel and Lodging $9,099 30 payments
  4. Honoraria $4,050 3 payments
  5. Food and Beverage $1,989 47 payments
  6. Debt forgiveness $28 1 payment
Products named General payments · program years 2019–2022
  1. Acuvue $36,500 70 payments
  2. DAILIES $18,609 21 payments
  3. Cequa $4,177 10 payments
  4. XIIDRA Ophthalmology $1,454 5 payments
  5. XIIDRA Opthalmics $229 2 payments
  6. Precision 1 $188 2 payments
  7. AdaptDx $113 1 payment
  8. BromSite $88 5 payments
  9. Xelpros $88 5 payments
  10. Multiple Brands Contact Lens $30 1 payment
  11. Other $44 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

130 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record